Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Atrinsic Inc. (PTIX) vs ZyVersa Therapeutics, Inc. (ZVSA)

Atrinsic Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $970.0K — 1.3× the size. ZyVersa Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 8 metrics below, Atrinsic Inc. leads on 5 and ZyVersa Therapeutics, Inc. on 3.

Valuation

Metric PTIX ZVSA Biotechnology median
P/E 0.35 n/m 7.88
P/S n/m n/m 11.47
P/B 0.82 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield 285.90% (3,679.60%) (28.84%)
Free cash flow yield (152.63%) (511.54%) (23.03%)

Profitability

Metric PTIX ZVSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (338.24%) 817.13% (57.72%)
Return on assets 390.69% (225.42%) (49.22%)
Return on invested capital (229.86%) 0.00% 0.00%

Growth

Metric PTIX ZVSA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 188.24% 50.71% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTIX ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 0.05 4.73
Net debt to EBITDA 0.52 0.00 0.96

Dividend

Metric PTIX ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric PTIX ZVSA Biotechnology median
Market cap 1.27m 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack